Led Miist Therapeutics's $7M funding round for biotech development.
Miist Therapeutics is setting a new standard in acute care with inhaled therapies that work in seconds, not hours
Miist Therapeutics is setting a new standard in acute care with inhaled therapies that work in seconds, not hours.